BLCOBausch & Lomb Corp

NYSE bausch.com


$ 17.62 $ -0.60 (-3.29 %)    

Monday, 16-Sep-2024 11:08:45 EDT
QQQ $ 470.91 $ -2.15 (-0.45 %)
DIA $ 416.29 $ 1.35 (0.33 %)
SPY $ 560.98 $ -0.49 (-0.09 %)
TLT $ 100.93 $ 0.30 (0.3 %)
GLD $ 238.45 $ -0.15 (-0.06 %)
$ 15.55
$ 18.22
$ 17.61 x 100
-- x --
$ 17.50 - $ 18.22
$ 13.16 - $ 17.85
150,761
na
5.47B
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 06-08-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-bausch--lomb

Needham analyst David Saxon reiterates Bausch & Lomb (NYSE:BLCO) with a Hold.

Core News & Articles

https://www.wsj.com/articles/bausch-plan-to-spin-off-eye-care-business-stuck-in-creditor-standoff-00e49ff8

 rbc-capital-reiterates-outperform-on-bausch--lomb-maintains-20-price-target

RBC Capital analyst Douglas Miehm reiterates Bausch & Lomb (NYSE:BLCO) with a Outperform and maintains $20 price target.

 hc-wainwright--co-maintains-buy-on-bausch--lomb-lowers-price-target-to-19

HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb (NYSE:BLCO) with a Buy and lowers the price target from ...

 deutsche-bank-maintains-hold-on-bausch--lomb-raises-price-target-to-18

Deutsche Bank analyst Pito Chickering maintains Bausch & Lomb (NYSE:BLCO) with a Hold and raises the price target from $...

Core News & Articles

RBC Capital analyst Douglas Miehm reiterates Bausch & Lomb (NYSE:BLCO) with a Outperform and maintains $20 price target.

 needham-reiterates-hold-on-bausch--lomb

Needham analyst David Saxon reiterates Bausch & Lomb (NYSE:BLCO) with a Hold.

 tech-stocks-on-track-for-best-session-in-5-months-ahead-of-fed-meeting-small-caps-target-highest-close-since-january-2022-whats-driving-markets-wednesday

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Commi...

 wall-street-remains-on-track-for-amd-led-rebound-ahead-of-fed-decision-meta-earnings-analyst-says-the-bull-tends-to-remain-despite-near-term-volatility

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro ...

 bausch--lomb-forecasts-2024-revenues-of-470b-480b-versus-prior-guidance-of-460b-470b-and-consensus-of-4661b-with-adjusted-ebitda-of-850m-900m-compared-to-prior-guidance-of-840m890m

2024 Financial Outlook2 Bausch + Lomb raised revenue and Adjusted EBITDA (non-GAAP)1 guidance for the full year of 2024 as fol...

 apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

 raymond-james-initiates-coverage-on-bausch--lomb-with-outperform-rating-announces-price-target-of-19

Raymond James analyst Gary Nachman initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Outperform rating and announce...

 evercore-isi-group-maintains-in-line-on-bausch--lomb-raises-price-target-to-155

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb (NYSE:BLCO) with a In-Line and raises the price target fr...

 why-is-clearside-biomedical-stock-gaining-today

Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer ra...

Core News & Articles

15 ePosters and In-Person Presentations Will Include Clinical Data on Blink™ NutriTears® Supplement for Dry Eyes, Blink® Triple...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION